EUCTR2010-024272-26-IT进行中（未招募）不适用
Comparison of the effects of Bimatoprost 0.01% and Timolol 0.5% on circadian intraocular pressure
IRCCS- FONDAZIONE G.B. BIETTI PER LO STUDIO E LA RICERCA IN OFTALMOLOGIA-ONLUS0 个研究点开始时间: 2012年3月20日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Signed informed consent • Age> 18 years • Diagnosis of glauocoma or ocular hypertension. The definition of glaucoma or ocular hypertension is based on the guidelines of the 'European Glaucoma Society • Patients newly diagnosed (Ocular hypertension and glaucoma) and never treated with ocular hypotensive drugs with any value tonometer and patients with OHT and POAG in ocular hypotensive drug therapy alone and with IOP <22mmHg at the screening visit.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 20
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 20
排除标准
- •Inability to sign informed consent • Ocular conditions that can interfere with the results of the study • Narrow angle or a history of acute attacks of glaucoma • eye infection or inflammation in the 3 months preceding the screening visit • eye surgery, or argon laser trabeculoplasty in the last three months. • History of hypersensitivity to benzalkonium chloride or other components contained in the formulation of study drug • Use of topical drugs that may interfere with the study medication • Causes of secondary increase of intraocular pressure • Contraindications to the use of systemic drugs in the studio
研究者
相似试验
已完成
3 期
Efficacy and safety of bimatoprost 0.01% for the treatment of eyebrow hypotrichosis: A randomized, double-blind, vehicle-controlled studyEyebrow hypotrichosisMadarosisTCTR20160911001Division of Dermatology, Ramathibodi Hospital, Mahidol University40
已完成
不适用
Comparable study between bimatoprost and latanoprost/timolo fixed combination in primary open angle glaucoma patientsPrimary open angle glaucoma patientsJPRN-UMIN000004595Department of Ophthalmology, Kyoto Prefectural University of Medicine80
进行中（未招募）
1 期
The Efficacy and Safety of Bimatoprost SR in Patients with Open-angle Glaucoma or Ocular HypertensioOpen-angle Glaucoma and Ocular HypertensionMedDRA version: 18.0 Level: HLGT Classification code 10018307 Term: Glaucoma and ocular hypertension System Organ Class: 10015919 - Eye disordersMedDRA version: 18.0 Level: PT Classification code 10030043 Term: Ocular hypertension System Organ Class: 10015919 - Eye disordersMedDRA version: 18.0 Level: PT Classification code 10030348 Term: Open angle glaucoma System Organ Class: 10015919 - Eye disordersEUCTR2014-003037-26-ESAllergan Limited600
进行中（未招募）
1 期
The Efficacy and Safety of Bimatoprost SR in Patients with Open-angle Glaucoma or Ocular HypertensioEUCTR2014-003037-26-HUAllergan Limited600
进行中（未招募）
1 期
The Efficacy and Safety of Bimatoprost SR in Patients with Open-angle Glaucoma or Ocular HypertensioOpen-angle Glaucoma and Ocular HypertensionMedDRA version: 20.0 Level: HLGT Classification code 10018307 Term: Glaucoma and ocular hypertension System Organ Class: 100000004853MedDRA version: 20.0 Level: PT Classification code 10030043 Term: Ocular hypertension System Organ Class: 10015919 - Eye disordersMedDRA version: 20.0 Level: PT Classification code 10030348 Term: Open angle glaucoma System Organ Class: 10015919 - Eye disordersEUCTR2014-003037-26-ATAllergan Limited600